Healthcare >> CEO Interviews >> November 15, 2010
Brian Culley joined ADVENTRX Pharmaceuticals, Inc., in December 2004 and currently serves as Chief Executive Officer, a position he has held since February 2010. He has served as the Principal Executive Officer since February 2009. From January 2007 to February 2010, he served as Chief Business Officer and Senior Vice President. From February 2006 to January 2007, Mr. Culley served as Senior Vice President, Business Development, and from December 2004 to February 2006, he served as Vice President, Business Development. From 2002 until 2004, Mr. Culley managed all strategic collaborations and licensing agreements for iTherx, Inc. (formerly, Immusol, Inc.), in San Diego, where his most recent title was Director of Business Development and Marketing. From 1999 until 2000, he was a Licensing and Marketing Associate at the University of California, San Diego department of technology transfer & intellectual property services, and from 1996 to 1999 he was a Research Associate for Neurocrine Biosciences, Inc., where he performed drug discovery research. Mr. Culley has over 15 years of experience in the biotechnology industry, including deal structure and negotiation, licensing, due diligence, market and competitive research, and venture funding. He received a B.S. in biology from Boston College, a master's in biochemistry from the University of California, Santa Barbara, and an MBA with an emphasis on private equity and entrepreneurship from the Johnson School at Cornell University. Profile
TWST: When we spoke last year, you told us you were in the midst of a restart and you were moving away from high-risk programs to pursue lower-cost, lower-risk strategies. Would you expand a little
